Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 03-2012 | 12-2011 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 40,999 | 27,482 |
| Marketable Securities | 1,992 | 626,099 |
| Receivables | 3,646,763 | 3,817,486 |
| Inventories | 915,794 | 871,582 |
| Income taxes - deferred | 2,145,500 | 1,468,794 |
| TOTAL | $6,751,048 | $7,354,155 |
| Non-Current Assets | ||
| PPE Net | 2,168,582 | 2,144,200 |
| Investments And Advances | 221,466 | 229,342 |
| Intangibles | 8,908,698 | 9,009,819 |
| Other Non-Current Assets | 911,769 | 919,650 |
| TOTAL | $12,210,515 | $12,303,011 |
| Total Assets | $18,961,563 | $19,657,166 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 476,129 | 417,030 |
| Accrued Expenses | 4,679,315 | 3,507,858 |
| TOTAL | $5,514,959 | $5,896,678 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 1,395,835 | 1,536,775 |
| TOTAL | $1,395,835 | $1,536,775 |
| Total Liabilities | $6,910,794 | $7,433,453 |
| Shareholders' Equity | ||
| Other shareholders' equity | 12,050,769 | 12,223,713 |
| TOTAL | $12,050,769 | $12,223,713 |
| Total Liabilities And Equity | $18,961,563 | $19,657,166 |